Form D · Biotechnology

Resolute Science, Inc.

San Diego, CA · CIK 0002023638

Offering snapshot reported Apr 3, 2026 · SEC filing

Reported sold
$2.93M
Offering amount: $4M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 3, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.46M$2.93MFeb 10, 2025: $1,350,000.00Feb 10, 2025Apr 3, 2026: $2,925,000.00Apr 3, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,350,000 → $2,925,000
  • Reported investors9 → 25

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 3, 2026Amendment$2,925,000$1,575,000vs Feb 10, 202525SEC filing
Feb 10, 2025Initial$1,350,000No comparison9SEC filing
May 16, 2024Initial$250,000No comparison1SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-537825

Source: Form D, filed Apr 3, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Faith Barnett Director, Executive
Andre Basbaum Director, Executive
James Mackay Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3210 Merryfield Row
San Diego, CA, 92121